A Phase 4 interventional study of Measles-Mumps-Rubella Vaccine and cryotherapy in Common Wart and Plantar Wart, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2020-06-16.
Sponsored by Assiut University · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Warts by Assiut University — 8 open to participants now, 8 under way, 3 of them phase 3. Warts · Assiut University.
Among the 17 studies in Warts by Assiut University, this one is the 12th largest by enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2017, is one of 2 in phase 4, and was the 3rd registered.
172 studies on the registry are indexed under Warts; 36 are open to participants now.
Browse Warts studies →8 of the 17 studies in Warts by Assiut University are open now. Recruiting first, the newest first:
Assiut University
Ages 18–50
Assiut University
Ages 12+
Assiut University
Ages 18+
Assiut University
Ages 11–80
Assiut University
Ages 18–60 · Healthy volunteers
Of the 19 Warts studies recruiting now, 11 (58%) set no upper age limit and 8 (42%) stop at 75 or younger; 12 take children under 18; 1 takes healthy volunteers.
This study: 16 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 1 · Phase 3 5 · Phase 4 2
First in 2017; this study’s year is marked. 2 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 48 is below the median of 70 across 156 interventional studies indexed under Warts.
Median enrollment 68 across the 15 interventional studies, 80 across the 2 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,188 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
4 of the studies in Warts by Assiut University that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07830979Phase 3Assiut UniversityHydrogen Peroxide 40% Versus Salicylic Acid 40% for Plantar Warts | 2027-09-20 |
| NCT07848100Phase 3Assiut UniversityIntralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts | 2027-10 |
| NCT07396714Assiut Universitythe Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts. | 2027-02-01 |
| NCT07041749Assiut UniversityMicroneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts | 2027-06-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 17 studies in Warts by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Warts are benign epidermal tumors caused by human papilloma virus, which are epitheliotropic non-enveloped double stranded DNA viruses. Transmission of warts occurs from direct person-to-person contact or indirectly by fomites . Warts appear in various forms including verruca vulgaris, plane, plantar, filiform, digitate and periungual.
Treatment of warts is difficult for patients and physicians . Currently Available treatment options include cryosurgery, laser, electrosurgery, bleomycin, and topical keratolytic applications; many of them are painful, ineffective, costly and prone for recurrences.
Cryotherapy, which uses liquid nitrogen to freeze tissues and destroy warts, is one of the most common and effective treatments. freezing causes local irritation, leading the host to mount an immune reaction against the virus.
Immunotherapy appears to enhance virus recognition by immune system; allowing clearance of treated wart, distant warts , and helps to prevent infection .Recently, intralesional immunotherapy using different antigens such as mumps, Candida, and tuberculin has been proved effective in the treatment of warts.
The exact mechanism of action of intralesional immunotherapy is still obscure. Intralesional antigen injection probably induces strong non specific inflammatory response against the human papilloma virus-infected cells.
It has been suggested that intralesional measles mumps rubella vaccine results in regression of warts via induction of immune system.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients under 16 years old.
Patients with single warts.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Measles-Mumps-Rubella Vaccine will be injected 0.5 ml into the largest wart at 2-week intervals until complete clearance was achieved or for a maximum of 3 treatments
Drug: Measles-Mumps-Rubella Vaccine
patients received cryotherapy with liquid nitrogen once every 2 weeks until complete clearance or for a maximum of 3 sessions
Procedure: cryotherapy
MMR vaccine will be injected 0.5 ml into the largest wart at 2-week intervals until complete clearance was achieved or for a maximum of 3 treatments. Response to treatment will be evaluated 1 month after the last session by decrease in the size of warts, decrease in the number of warts and photographic comparison. The clinical response was graded into complete (complete cure), partial (if there was a decrease in the size and\\or a decrease in the total number of warts), and no response (no change in size and number of warts).
Also known as: MMR
patients received cryotherapy with liquid nitrogen once every 2 weeks until complete clearance or for a maximum of 3 sessions.Response to treatment will be evaluated 1 month after the last session by decrease in the size of warts, decrease in the number of warts and photographic comparison. The clinical response was graded into complete (complete cure), partial (if there was a decrease in the size and\\or a decrease in the total number of warts), and no response (no change in size and number of warts).
Cure rate
Assess cure rate of MMR vaccine and cryotherapy in treatment of common and planter warts (complete disappearance of lesions) one month after last session, compare efficacy of both measures.
Time frame: 60 days
Detection of partial response to both measures
if there was a decrease in the size or a decrease in the total number of warts
Time frame: 60 days
Side effects
Detection of post procedure side effects such as flu like symptoms, pain , hypopigmentation.
Time frame: 60 days
Plan to share: No
Ran from Aug 2017 to primary completion in Mar 2018, 7 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Measles-Mumps-Rubella Vaccine